Dr. Rongliang Lou is a medicinal chemist with a Ph.D. from the Chinese Academy of Sciences. He co-invented Samidorphan, a key component of the FDA-approved drug Lybalvi (2021), and pioneered the novel antibiotic Radezolid into clinical development. Currently, he serves as an Executive Director at Innovent, focusing on development of innovative ADC technologies.